Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob S Elkins

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Epidemiology|July 20, 2007
Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older womenJacob S Elkins, S Claiborne Johnston, Elad Ziv, et al.
Archives of Neurology|September 12, 2002
Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attackJacob S Elkins, Stephen Sidney, Daryl R Gress, et al.
Annals of Neurology|June 29, 2005
Pre-existing hypertension and the impact of stroke on cognitive functionJacob S Elkins, Kristine Yaffe, Jane A Cauley, et al.
Circulation|May 1, 2004
Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysisNaomi S Bardach, Scott J Olson, Jacob S Elkins, et al.
Lancet (London, England)|January 30, 2007
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attackS Claiborne Johnston, Peter M Rothwell, Mai N Nguyen-Huynh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2011
Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosisJames P Sheridan, Ying Zhang, Katherine Riester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2014
In vivo maintenance of human regulatory T cells during CD25 blockadeDavid J Huss, Devangi S Mehta, Akanksha Sharma, et al.
Neurology and Therapy|November 26, 2024
Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular DystrophyCraig M McDonald, Jacob S Elkins, Sai Dharmarajan, et al.
JAMA Neurology|May 12, 2025
Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical TrialKrista Vandenborne, Glenn A Walter, Volker Straub, et al.
Nature Medicine|October 9, 2024
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Epidemiology|July 20, 2007
Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older womenJacob S Elkins, S Claiborne Johnston, Elad Ziv, et al.
Archives of Neurology|September 12, 2002
Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attackJacob S Elkins, Stephen Sidney, Daryl R Gress, et al.
Annals of Neurology|June 29, 2005
Pre-existing hypertension and the impact of stroke on cognitive functionJacob S Elkins, Kristine Yaffe, Jane A Cauley, et al.
Circulation|May 1, 2004
Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysisNaomi S Bardach, Scott J Olson, Jacob S Elkins, et al.
Lancet (London, England)|January 30, 2007
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attackS Claiborne Johnston, Peter M Rothwell, Mai N Nguyen-Huynh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2011
Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosisJames P Sheridan, Ying Zhang, Katherine Riester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2014
In vivo maintenance of human regulatory T cells during CD25 blockadeDavid J Huss, Devangi S Mehta, Akanksha Sharma, et al.
Neurology and Therapy|November 26, 2024
Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular DystrophyCraig M McDonald, Jacob S Elkins, Sai Dharmarajan, et al.
JAMA Neurology|May 12, 2025
Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical TrialKrista Vandenborne, Glenn A Walter, Volker Straub, et al.
Nature Medicine|October 9, 2024
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Pageof 2